Skip to main content

Table 2 (abstract A80). Medications at baseline for patients with DLE (Skin-Limited and SLE). Topical steroids and hydroxychloroquine were most frequently prescribed

From: Proceedings of the 2019 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting

Medication N, (%)
Topical steroids 132 (65%)
Hydroxychloroquine 118 (58%)
Other immunomodulatory medications 59 (29%)
• Prednisone/Methylprednisolone 46 (22%)
• Mycophenolate mofetil 16 (8%)
• Rituximab 5 (2%)
• Methotrexate 4 (2%)
• Dapsone 4 (2%)
• Azathioprine 4 (2%)
• Quinacrine 1 (0.5%)
• Thalidomide 1 (0.5%)
Topical calcineurin inhibitors 40 (20%)
None 13 (6%)